Author: Khyati Shah

In a significant development towards India’s vaccination efforts, the Drug Controller General of India, has approved Phase II and Phase III study protocols for HGCO19, India’s first mRNA-based COVID-19 vaccine,... Read More

The Central Drugs Standard Control Organisation (CDSCO), India's National Regulatory Authority, has approved Gennova Biopharmaceuticals Limited's work on the country's first mRNA-based COVID-19 vaccine for its clinical data of the... Read More

India’s first domestically developed mRNA-based Covid-19 vaccine candidate has been found safe in its interim Phase 1 clinical trials, and the national drugs regulator has granted approval to its maker,... Read More

Bain Capital-backed Emcure Pharmaceuticals filed preliminary papers with capital markets regulator SEBI to raise funds through an initial share sale. The initial public offering comprises fresh issuance of equity shares worth... Read More

Emcure Pharmaceuticals Limited, one of India's biggest pharmaceutical businesses, has filed its Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) to raise funds... Read More

mcure Pharmaceuticals on Thursday said it has filed draft papers with Sebi for initial public offer (IPO). Sources said the size of the offer could be in the range of... Read More

Emcure Pharmaceuticals Limited, one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas, has filed... Read More

Emcure Pharmaceuticals Limited has filed its draft IPO (Initial Public Offering) papers with capital markets regulator SEBI. The company is looking to raise more than Rs 1,100 crore through the... Read More

•The mRNA-based vaccine has been developed in partnership with Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC). •Gennova Biopharmaceuticals Ltd., which is a Pune-based biotechnology company, had submitted... Read More

Gennova Biopharmaceuticals on Tuesday received approval from the Drugs Controller General of India (DCGI) to start Phase II/III trials for its Covid-19 vaccine. Gennova has developed the HGCO19 Covid-19 vaccine,... Read More